EBITDA for Cardinal Health (CAH)
According to Cardinal Health's latest reported financial statements, the company's current EBITDA (TTM) is $3.23B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$3.23B
YoY change
+58.3%
5Y CAGR
N/A
Peak year (2025)
$3.11B
Cumulative EBITDA
$51.94B
EBITDA history chart for Cardinal Health (CAH) from 1986 to 2025
EBITDA history table for Cardinal Health (CAH) from 1986 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $3.11B | +58.3% | ||
| 2024 | $1.96B | +36.3% | ||
| 2023 | $1.44B | +2516.4% | ||
| 2022 | $55.00M | -95.7% | ||
| 2021 | $1.29B | -149.1% | ||
| 2020 | -$2.62B | -186.1% | ||
| 2019 | $3.04B | +168.8% | ||
| 2018 | $1.13B | -60.1% | ||
| 2017 | $2.84B | -8.2% | ||
| 2016 | $3.10B | +20.9% | ||
| 2015 | $2.56B | +7.1% | ||
| 2014 | $2.39B | +69.7% | ||
| 2013 | $1.41B | -33.5% | ||
| 2012 | $2.12B | +10.1% | ||
| 2011 | $1.92B | +21.8% | ||
| 2010 | $1.58B | -3.7% | ||
| 2009 | $1.64B | -1.0% | ||
| 2008 | $1.66B | -9.8% | ||
| 2007 | $1.84B | -17.1% | ||
| 2006 | $2.22B | +0.4% | ||
| 2005 | $2.21B | -18.3% | ||
| 2004 | $2.70B | +4.1% | ||
| 2003 | $2.59B | +17.4% | ||
| 2002 | $2.21B | +25.0% | ||
| 2001 | $1.77B | +15.0% | ||
| 2000 | $1.54B | +20.1% | ||
| 1999 | $1.28B | +18.9% | ||
| 1998 | $1.08B | +16.4% | ||
| 1997 | $924.80M | +177.5% | ||
| 1996 | $333.30M | +16.8% | ||
| 1995 | $285.30M | +177.0% | ||
| 1994 | $103.00M | +55.6% | ||
| 1993 | $66.20M | +24.9% | ||
| 1992 | $53.00M | +34.9% | ||
| 1991 | $39.30M | +40.9% | ||
| 1990 | $27.90M | +32.9% | ||
| 1989 | $21.00M | +40.0% | ||
| 1988 | $15.00M | -6.3% | ||
| 1987 | $16.00M | +53.8% | ||
| 1986 | $10.40M | — |
EBITDA values are taken from Cardinal Health's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Cardinal Health (CAH) reported EBITDA of $3.11B – surged 58.3% year-over-year.
Across 2015–2025 (10 years), Cardinal Health EBITDA produced a CAGR of +2.0% – sustaining 3 straight years of year-over-year growth.
2025 marks the peak EBITDA at $3.11B, with the historical low of -$2.62B recorded in 2020.
Among 8 Healthcare peers, Cardinal Health (CAH) ranks 9th; the peer median for EBITDA is $24.21B.
Cardinal Health EBITDA by Year
Cardinal Health EBITDA 2025: $3.11B
Cardinal Health EBITDA in 2025 was $3.11B, surged 58.3% from 2024. This figure represents the highest annual value in the available history.
Cardinal Health EBITDA 2024: $1.96B
Cardinal Health EBITDA in 2024 was $1.96B, surged 36.3% from 2023.
Cardinal Health EBITDA 2023: $1.44B
Cardinal Health EBITDA in 2023 was $1.44B, surged 2516.4% from 2022.
Cardinal Health EBITDA 2022: $55.00M
Cardinal Health EBITDA in 2022 was $55.00M, plunged 95.7% below 2021.
Cardinal Health EBITDA 2021: $1.29B
Cardinal Health EBITDA in 2021 was $1.29B.
See more financial history for Cardinal Health (CAH).
Sector peers — EBITDA
Companies in the same sector as Cardinal Health, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Cardinal Health's EBITDA?
- Latest reported EBITDA for Cardinal Health (CAH) is $3.23B (period ending December 31, 2025).
How has Cardinal Health EBITDA changed year-over-year?
- Cardinal Health (CAH) EBITDA changed +58.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Cardinal Health EBITDA?
- Cardinal Health (CAH) EBITDA compound annual growth rate is +2.0% over the most recent 10 years available.
When did Cardinal Health EBITDA hit its highest annual value?
- Cardinal Health EBITDA reached its highest annual value of $3.11B in 2025.
What was Cardinal Health EBITDA in 2024?
- Cardinal Health (CAH) EBITDA in 2024 was $1.96B.
What was Cardinal Health EBITDA in 2025?
- Cardinal Health (CAH) EBITDA in 2025 was $3.11B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CAH Overview
Company profile, financial tools, and key metrics
CAH Revenue Counter
Earns $7,753 every second. See per minute, hour, and day.
CAH Earnings Counter
Earns $52.83 per second net profit. See per minute, hour, and day.
CAH Economic Scale
Exceeds Hungary's GDP. Compare with world economies.
CAH What If Invested
What if you had invested $1,000? See historical returns from any date.
CAH How It Makes Money
Discover visual breakdown of $244.49B in revenue — where it comes from and where it goes.
CAH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CAH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CAH Daily Price Character
Balanced · 48.0% historical win rate (green days). Streaks & record days.
CAH Buybacks
3.91% TTM buyback yield. Shareholder yield & SBC comparison.
CAH Stock Split History
11 splits on record. Dates, ratios, and cumulative multiple.
CAH Dividend Profile
Yield: 1.01%. Safety: 5/8. See full history.
CAH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CAH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.